In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 11, 1997, Pages 827-833

  Facinelli, B ^a   Magi, G ^a   Prenna, M ^b   Ripa, S ^b   Varaldo, P E ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Dept Molec Cell and Anim Biol   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CELL STRAIN CACO 2; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030678585     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01700413     Document Type: Article

References (35)

1. Schuchat A, Swaminathan B, Broome CV: Epidemiology of human listeriosis. Clinical Microbiology Reviews 1991, 4: 169-183.
2. Lorber B: Listeriosis. Clinical Infectious Diseases 1997, 24: 1-9.
3. Farber JM, Peterkin PI: Listeria monocytogenes, a food-borne pathogen. Microbiological Reviews 1991, 55: 476-511.
4. Schuchat A, Deaver KA, Wenger JD, Plikaytis BD, Mascola L, Pinner RW, Reingold AL, Broome CV, and the Listeria Study Group: Role of foods in sporadic listeriosis. I: Case-control study of dietary risk factors. Journal of the American Medical Association 1992, 267: 2041-2045.
5. Pinner RW, Schuchat A, Swaminathan B, Hayes PS, Deaver KA, Weaver RE, Plikaytis BD, Reeves M, Broome CV, Wenger JD, and the Listeria Study Group: Role of foods in sporadic listeriosis. II: Microbiologic and epidemiologic investigation. Journal of the American Medical Association 1992, 267: 2046-2050.
6. Jones EM, MacGowan AP: Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 165-175.
7. Hof H, Nichterlein T, Kretschmar M: Management of listeriosis. Clinical Microbiology Reviews 1997, 10: 345-357.
8. Charpentier E, Gerbaud G, Jacquet C, Rocourt J, Courvalin P: Incidence of antibiotic resistance in Listeria species. Journal of Infectious Diseases 1995, 172: 277-281.
9. Marget W, Seeliger HPR: Listeria monocytogenes: therapeutic possibilities and problems. Infection 1988, 16, Supplement 2: 175-177.
10. Southwick FS, Punch DL: Intracellular pathogenesis of listeriosis. New England Journal of Medicine 1996, 334: 770-776.
11. van den Broek PJ: Antimicrobial drugs, microorganisms, and phagocytes. Reviews of Infectious Diseases 1989, 11: 213-245.
12. Hof H: Intracellular microorganisms: a particular problem for therapy. Infection 1991, 19, Supplement 4: 193-194.
13. Piddock LJV: New quinolones and gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1994, 38: 163-169.
14. Eliopoulos GM: In vitro activity of fluoroquinolones against gram-positive bacteria. Drugs 1995, 49, Supplement 2: 48-57.
15. Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y, Kashimoto S, Yoshida H, Kojima T, Ohue T, Fujimoto K, Nakamura M, Hashimoto M, Shimizu M: In vitro and in vivo antibacterial activity of AT-4110, a new broad-spectrum quinolone. Antimicrobial Agents and Chemotherapy 1989, 33: 1167-1173.
16. Kojima T, Inoue M, Mitsuhashi S: In vitro activity of AT-4110 against clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 1989, 33: 1980-1988.
17. Chin NX, Gu JW, Yu KW, Zhang YX, Neu HC: In vitro activity of sparfloxacin. Antimicrobial Agents and Chemotherapy 1991, 35: 567-571.
18. Briggs Gooding B, Jones RN: In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrobial Agents and Chemotherapy 1993, 37: 2615-2622.
19. Eliopoulos GM, Klimm K, Eliopoulos CT, Ferraro MJ, Moellering RC: In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1993, 37: 366-370.
20. Neu HC, Chin NX: In vitro activity of the fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 1994, 38: 2615-2622.
21. Pine L, Weaver RE, Carlone GM, Pienta PA, Rocourt J, Goebel W, Kathariou S, Bibb WF, Malcolm GB: Listeria monocytogenes ATCC 35152 and NCTC 7973 contain a nonhemolytic, nonvirulent variant. Journal of Clinical Microbiology 1987, 25: 2247-2251.
22. Facinelli B, Varaldo PE, Toni M, Casolari C, Fabio U: Ignorance about listeria. British Medical Journal 1989, 299: 738.
23. Facinelli B, Giovanetti E, Varaldo PE, Casolari C, Fabio U: Antibiotic resistance in foodborne listeria. Lancet 1991, 338: 1272.
24. Facinelli B, Giovanetti E, Casolari C, Varaldo PE: Interactions with lectins and agglutination profiles of clinical, food, and environmental isolates of Listeria. Journal of Clinical Microbiology 1994, 32: 2929-2935.
25. Roberts MC, Facinelli B, Giovanetti E, Varaldo PE: Transferable erythromycin resistance in Listeria spp. isolated from food. Applied and Environmental Microbiology 1996, 62: 269-270.
26. Swaminathan B, Rocourt J, Bille J: Listeria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1995, p. 341-348.
27. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Villanova, PA, 1997.
28. Comité de l'Antibiogramme de la Société Française de Microbiologie: Statement 1996 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clinical Microbiology and Infection 1996, 2, Supplement 1: 46-49.
29. Cormican GC, Jones RN: In-vitro activity of trovafloxacin (CP 99,129) tested by two methods against 150 vancomycin-resistant enterococcal isolates. Journal of Antimicrobial Chemotherapy 1996, 37: 847-849.
30. National Committee for Clinical Laboratory Standards: Methods for determining bactericidal activity of antimicrobial agents. Tentative guidelines M26-T. NCCLS, Villanova, PA, 1992.
31. Pascual A, Garcìa I, Ballesta S, Perea EJ: Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrobial Agents and Chemotherapy 1997, 41: 274-277.
32. Appleman MD, Cherubin CE, Heseltine PNR, Stratton CW: Susceptibility testing of Listeria monocytogenes: a reassessment of bactericidal activity as a predictor for clinical outcome. Diagnostic Microbiology and Infectious Disease 1991, 14: 311-317.
33. Nichterlein T, Kretschmar M, Budeanu C, Bauer J, Linss W, Hof H: Bay Y 318, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells. Antimicrobial Agents and Chemotherapy 1994, 38: 1501-1506.
34. Michelet C, Avril JL, Cartier F, Berche P: Inhibition of intracellular growth of Listeria monocytogenes by antibiotics. Antimicrobial Agents and Chemotherapy 1994, 38: 438-446.
35. Michelet C, Avril JL, Arvieux C, Jacquelinet C, Cartier F: Comparative activities of new fluoroquinolones, alone and in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes. Antimicrobial Agents and Chemotherapy 1997, 41: 60-65.